LifeMD (LFMD) Competitors $11.32 +0.06 (+0.53%) Closing price 04:00 PM EasternExtended Trading$11.32 +0.00 (+0.04%) As of 06:24 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock LFMD vs. VCYT, ADUS, PACS, ARDT, LFST, PGNY, GRAL, NHC, TDOC, and VRDNShould you be buying LifeMD stock or one of its competitors? The main competitors of LifeMD include Veracyte (VCYT), Addus HomeCare (ADUS), PACS Group (PACS), Ardent Health (ARDT), LifeStance Health Group (LFST), Progyny (PGNY), GRAIL (GRAL), National HealthCare (NHC), Teladoc Health (TDOC), and Viridian Therapeutics (VRDN). These companies are all part of the "healthcare" industry. LifeMD vs. Its Competitors Veracyte Addus HomeCare PACS Group Ardent Health LifeStance Health Group Progyny GRAIL National HealthCare Teladoc Health Viridian Therapeutics Veracyte (NASDAQ:VCYT) and LifeMD (NASDAQ:LFMD) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, institutional ownership, profitability, earnings, valuation, media sentiment, analyst recommendations and dividends. Do insiders and institutionals believe in VCYT or LFMD? 35.5% of LifeMD shares are owned by institutional investors. 1.4% of Veracyte shares are owned by insiders. Comparatively, 18.4% of LifeMD shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Is VCYT or LFMD more profitable? Veracyte has a net margin of 7.13% compared to LifeMD's net margin of -4.58%. Veracyte's return on equity of 6.14% beat LifeMD's return on equity.Company Net Margins Return on Equity Return on Assets Veracyte7.13% 6.14% 5.60% LifeMD -4.58%N/A -15.19% Do analysts prefer VCYT or LFMD? Veracyte currently has a consensus target price of $40.90, indicating a potential upside of 53.47%. LifeMD has a consensus target price of $13.86, indicating a potential upside of 22.41%. Given Veracyte's higher possible upside, equities research analysts clearly believe Veracyte is more favorable than LifeMD.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Veracyte 1 Sell rating(s) 1 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.70LifeMD 0 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 3.00 Which has preferable valuation and earnings, VCYT or LFMD? Veracyte has higher revenue and earnings than LifeMD. LifeMD is trading at a lower price-to-earnings ratio than Veracyte, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVeracyte$445.76M4.68$24.14M$0.4165.00LifeMD$212.45M2.42-$18.88M-$0.34-33.29 Which has more volatility and risk, VCYT or LFMD? Veracyte has a beta of 2.07, suggesting that its stock price is 107% more volatile than the S&P 500. Comparatively, LifeMD has a beta of 2.4, suggesting that its stock price is 140% more volatile than the S&P 500. Does the media favor VCYT or LFMD? In the previous week, LifeMD had 1 more articles in the media than Veracyte. MarketBeat recorded 5 mentions for LifeMD and 4 mentions for Veracyte. LifeMD's average media sentiment score of 1.07 beat Veracyte's score of 0.93 indicating that LifeMD is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Veracyte 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive LifeMD 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryVeracyte beats LifeMD on 10 of the 17 factors compared between the two stocks. Get LifeMD News Delivered to You Automatically Sign up to receive the latest news and ratings for LFMD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding LFMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LFMD vs. The Competition Export to ExcelMetricLifeMDMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$514.49M$7.24B$5.53B$9.13BDividend YieldN/A2.83%5.06%4.01%P/E Ratio-33.2934.3728.5819.57Price / Sales2.4230.12372.6479.65Price / CashN/A24.5224.7227.51Price / Book-125.788.298.235.56Net Income-$18.88M$236.06M$3.19B$252.37M7 Day Performance-7.21%1.49%5.46%3.11%1 Month Performance-9.15%2.70%9.39%11.74%1 Year Performance83.47%34.13%30.48%17.41% LifeMD Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LFMDLifeMD1.5113 of 5 stars$11.32+0.5%$13.86+22.4%+82.5%$514.49M$212.45M-33.29230Analyst ForecastVCYTVeracyte3.5912 of 5 stars$26.34-4.3%$40.90+55.3%+19.0%$2.15B$445.76M64.25790ADUSAddus HomeCare4.9782 of 5 stars$110.62-1.1%$142.57+28.9%-8.3%$2.06B$1.15B24.9749,703Positive NewsPACSPACS Group2.8128 of 5 stars$12.51-4.8%$34.29+174.1%-59.2%$2.00B$3.11B0.0032,433ARDTArdent Health3.3441 of 5 stars$13.34-0.4%$20.67+54.9%N/A$1.92B$5.97B8.1824,900Analyst DowngradeLFSTLifeStance Health Group3.0734 of 5 stars$4.68-2.3%$8.50+81.6%-15.4%$1.86B$1.25B-46.8010,218PGNYProgyny1.0962 of 5 stars$21.450.0%$23.45+9.3%-19.8%$1.84B$1.17B37.63310Analyst RevisionGRALGRAIL0.6796 of 5 stars$44.85-4.0%$31.50-29.8%+175.0%$1.68B$125.60M-0.741,360NHCNational HealthCareN/A$104.23-3.9%N/A-14.6%$1.61B$1.37B13.0612,400Positive NewsTDOCTeladoc Health2.7997 of 5 stars$8.06-2.8%$9.60+19.1%-11.3%$1.45B$2.57B-1.365,500VRDNViridian Therapeutics3.1767 of 5 stars$15.89+1.4%$37.56+136.3%+22.7%$1.28B$300K-4.1350 Related Companies and Tools Related Companies Veracyte Competitors Addus HomeCare Competitors PACS Group Competitors Ardent Health Competitors LifeStance Health Group Competitors Progyny Competitors GRAIL Competitors National HealthCare Competitors Teladoc Health Competitors Viridian Therapeutics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LFMD) was last updated on 7/14/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredAn extra $1,000 per month?A little-known Title 15 provision could let you collect instant payouts — $100 to $1,000 — directly from your ...TradeSmith | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LifeMD, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share LifeMD With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LFMD Stock Alerts